Provided by Tiger Fintech (Singapore) Pte. Ltd.

Kezar Life Sciences Inc.

4.34
-0.2500-5.45%
Post-market: 4.340.00000.00%16:04 EDT
Volume:40.73K
Turnover:180.20K
Market Cap:31.71M
PE:-0.40
High:4.69
Open:4.65
Low:4.26
Close:4.59
Loading ...

Kalamazoo Resources Concludes Funding Arrangement with Lind Partners

TIPRANKS
·
11 Mar

Kezar Life Sciences Inc expected to post a loss of $2.88 a share - Earnings Preview

Reuters
·
10 Mar

TD Cowen Keeps Their Buy Rating on Kezar Life Sciences (KZR)

TIPRANKS
·
28 Feb

William Blair Sticks to Its Hold Rating for Kezar Life Sciences (KZR)

TIPRANKS
·
25 Feb

Kezar Life Sciences to Present at Virtual Kol Event Hosted by William Blair on Zetomipzomib Clinical Development in Autoimmune Hepatitis and Provide a Safety Update From the Palizade Trial for Lupus Nephritis on February 27, 2025

THOMSON REUTERS
·
19 Feb

Kalamazoo Resources Issues Over Two Million Shares Under Placement Agreement

TIPRANKS
·
07 Feb

Kalamazoo Resources Ltd. Quotes New Securities on ASX

TIPRANKS
·
07 Feb

BRIEF-Kezar Life Sciences Files For Mixed Shelf Of Upto $400 Million

Reuters
·
06 Feb

Kezar Life Sciences Files $400 Million Mixed Securities Shelf

MT Newswires Live
·
06 Feb

Kezar Life Sciences files $400M mixed securities shelf

TIPRANKS
·
06 Feb

Kezar Life Sciences, Inc. Files for Mixed Shelf of Upto $400 Mln

THOMSON REUTERS
·
06 Feb

Kalamazoo Resources Ltd Advances Gold Projects with Strategic Agreements and Financial Initiatives

TIPRANKS
·
24 Jan

Kalamazoo Resources Reports Quarterly Financials with Positive Cash Flow from Financing

TIPRANKS
·
24 Jan

Kalamazoo Resources Issues New Shares to Strengthen Market Position

TIPRANKS
·
13 Jan

Kezar Life Sciences Is Maintained at Equal-Weight by Wells Fargo

Dow Jones
·
19 Dec 2024

Kalamazoo Resources Completes Promising Drill Program

TIPRANKS
·
19 Dec 2024